- Home
- INLF vs PRLD Comparison
INLF vs PRLD Comparison
Compare INLF & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INLF
- PRLD
- Stock Information
- Founded
- INLF 2016
- PRLD 2016
- Country
- INLF China
- PRLD United States
- Employees
- INLF N/A
- PRLD N/A
- Industry
- INLF Industrial Machinery/Components
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- INLF Industrials
- PRLD Health Care
- Exchange
- INLF Nasdaq
- PRLD Nasdaq
- Market Cap
- INLF 68.4M
- PRLD 73.7M
- IPO Year
- INLF 2025
- PRLD 2020
- Fundamental
- Price
- INLF $2.43
- PRLD $0.87
- Analyst Decision
- INLF
- PRLD Strong Buy
- Analyst Count
- INLF 0
- PRLD 2
- Target Price
- INLF N/A
- PRLD $4.50
- AVG Volume (30 Days)
- INLF 1.5M
- PRLD 196.9K
- Earning Date
- INLF 01-01-0001
- PRLD 03-04-2025
- Dividend Yield
- INLF N/A
- PRLD N/A
- EPS Growth
- INLF 60.54
- PRLD N/A
- EPS
- INLF 0.10
- PRLD N/A
- Revenue
- INLF $14,523,935.00
- PRLD $3,000,000.00
- Revenue This Year
- INLF N/A
- PRLD N/A
- Revenue Next Year
- INLF N/A
- PRLD N/A
- P/E Ratio
- INLF $28.79
- PRLD N/A
- Revenue Growth
- INLF 73.92
- PRLD N/A
- 52 Week Low
- INLF $2.29
- PRLD $0.80
- 52 Week High
- INLF $21.00
- PRLD $6.80
- Technical
- Relative Strength Index (RSI)
- INLF N/A
- PRLD 37.59
- Support Level
- INLF N/A
- PRLD $0.87
- Resistance Level
- INLF N/A
- PRLD $1.01
- Average True Range (ATR)
- INLF 0.00
- PRLD 0.08
- MACD
- INLF 0.00
- PRLD -0.02
- Stochastic Oscillator
- INLF 0.00
- PRLD 0.90
About INLF INLIF LIMITED Ordinary Shares
INLIF Ltd is a holding company and does business through its subsidiary. It is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms also a provider of installation services and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.